Sarcoma produced by subdermal administration of metaphenylenediamine and metaphenylenediamine hydrochloride.
D000814:Aniline Compounds; D000818:Animals; D002273:Carcinogens; D006801:Humans; D010655:Phenylenediamines; D012509:Sarcoma; D012513:Sarcoma, Experimental
D000814:Aniline Compounds; D002273:Carcinogens; D010655:Phenylenediamines; C008381:3-phenylenediamine
ANILINE COMPOUNDS; CARCINOGENS; SARCOMA, EXPERIMENTAL